| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 17 | 2022 | 855 | 1.620 |
Why?
|
| Amyloid beta-Peptides | 15 | 2018 | 246 | 0.960 |
Why?
|
| tau Proteins | 8 | 2022 | 216 | 0.760 |
Why?
|
| Memory Disorders | 4 | 2013 | 295 | 0.720 |
Why?
|
| Plaque, Amyloid | 6 | 2018 | 65 | 0.680 |
Why?
|
| alpha-Synuclein | 6 | 2021 | 118 | 0.660 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2009 | 650 | 0.640 |
Why?
|
| Neurodegenerative Diseases | 4 | 2012 | 264 | 0.600 |
Why?
|
| Imidazolidines | 1 | 2015 | 8 | 0.560 |
Why?
|
| Tromethamine | 1 | 2015 | 9 | 0.560 |
Why?
|
| Fixatives | 1 | 2015 | 28 | 0.550 |
Why?
|
| Mice, Transgenic | 14 | 2022 | 4143 | 0.540 |
Why?
|
| Histocytochemistry | 1 | 2015 | 185 | 0.530 |
Why?
|
| Formaldehyde | 1 | 2015 | 114 | 0.520 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 131 | 0.520 |
Why?
|
| Prostaglandins I | 1 | 2013 | 2 | 0.480 |
Why?
|
| Tauopathies | 1 | 2014 | 63 | 0.480 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2013 | 5 | 0.470 |
Why?
|
| Xanthines | 1 | 2013 | 29 | 0.460 |
Why?
|
| Brain | 17 | 2021 | 4113 | 0.460 |
Why?
|
| Parkinson Disease | 3 | 2005 | 708 | 0.460 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 39 | 0.450 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 7 | 2008 | 521 | 0.440 |
Why?
|
| Physical Conditioning, Animal | 5 | 2020 | 112 | 0.430 |
Why?
|
| Memory | 2 | 2018 | 429 | 0.390 |
Why?
|
| Behavior, Animal | 2 | 2013 | 709 | 0.380 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2009 | 7 | 0.370 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 7222 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 1491 | 0.350 |
Why?
|
| Amyloid beta-Protein Precursor | 6 | 2012 | 137 | 0.340 |
Why?
|
| Animals | 40 | 2022 | 59536 | 0.330 |
Why?
|
| Endopeptidases | 4 | 2005 | 220 | 0.330 |
Why?
|
| Microglia | 1 | 2009 | 164 | 0.320 |
Why?
|
| Flurbiprofen | 2 | 2007 | 5 | 0.320 |
Why?
|
| Models, Biological | 2 | 2008 | 3254 | 0.300 |
Why?
|
| Anxiety | 2 | 2013 | 1179 | 0.300 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 24 | 0.290 |
Why?
|
| Neurons | 4 | 2009 | 2287 | 0.290 |
Why?
|
| Peptide Fragments | 6 | 2013 | 1271 | 0.280 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 374 | 0.280 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 2 | 2018 | 2 | 0.280 |
Why?
|
| Raphe Nuclei | 2 | 2003 | 35 | 0.280 |
Why?
|
| Mice | 25 | 2022 | 34495 | 0.270 |
Why?
|
| Central Nervous System | 1 | 2007 | 436 | 0.260 |
Why?
|
| Ubiquitin | 2 | 2021 | 344 | 0.240 |
Why?
|
| Ethanol | 2 | 2003 | 264 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 925 | 0.230 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2002 | 2 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2021 | 589 | 0.230 |
Why?
|
| Astrocytes | 2 | 2003 | 368 | 0.220 |
Why?
|
| S100 Proteins | 1 | 2002 | 181 | 0.210 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 210 | 0.210 |
Why?
|
| Gene Dosage | 1 | 2005 | 829 | 0.210 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 2021 | 1 | 0.200 |
Why?
|
| Cycas | 1 | 2021 | 1 | 0.200 |
Why?
|
| Indans | 1 | 2021 | 68 | 0.200 |
Why?
|
| Microscopy | 2 | 2019 | 182 | 0.200 |
Why?
|
| Lactones | 1 | 2021 | 94 | 0.190 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2020 | 19 | 0.190 |
Why?
|
| Sulfones | 1 | 2021 | 143 | 0.180 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2021 | 200 | 0.180 |
Why?
|
| Cyclooxygenase 2 | 2 | 2021 | 483 | 0.180 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 202 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 268 | 0.180 |
Why?
|
| Amyloid Precursor Protein Secretases | 5 | 2008 | 99 | 0.180 |
Why?
|
| Optical Imaging | 1 | 2021 | 157 | 0.180 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 215 | 0.180 |
Why?
|
| Nerve Degeneration | 2 | 2014 | 148 | 0.170 |
Why?
|
| Spinal Cord | 2 | 2014 | 690 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 204 | 0.160 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 459 | 0.160 |
Why?
|
| Maze Learning | 3 | 2013 | 132 | 0.160 |
Why?
|
| Tissue Fixation | 2 | 2015 | 136 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 6942 | 0.150 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 575 | 0.150 |
Why?
|
| Microvessels | 1 | 2018 | 135 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 471 | 0.140 |
Why?
|
| Liposomes | 2 | 2016 | 684 | 0.140 |
Why?
|
| Angiotensins | 1 | 2015 | 10 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2013 | 71 | 0.140 |
Why?
|
| Polymyxin B | 1 | 2015 | 53 | 0.130 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 226 | 0.130 |
Why?
|
| Antigens | 1 | 2015 | 292 | 0.130 |
Why?
|
| Synucleins | 2 | 2005 | 13 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2015 | 281 | 0.130 |
Why?
|
| Biological Assay | 1 | 2016 | 177 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 585 | 0.120 |
Why?
|
| Cyclooxygenase 1 | 1 | 2013 | 67 | 0.120 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 24 | 0.110 |
Why?
|
| Serotonin Receptor Agonists | 2 | 2003 | 20 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 81 | 0.110 |
Why?
|
| Amyloid | 1 | 2013 | 97 | 0.110 |
Why?
|
| Ethanolamines | 1 | 2012 | 34 | 0.110 |
Why?
|
| Presenilin-1 | 1 | 2012 | 71 | 0.110 |
Why?
|
| Hippocampus | 3 | 2013 | 915 | 0.110 |
Why?
|
| Drug Design | 2 | 2021 | 375 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 200 | 0.110 |
Why?
|
| Molecular Structure | 3 | 2021 | 515 | 0.110 |
Why?
|
| Dementia | 2 | 2008 | 453 | 0.110 |
Why?
|
| Fear | 1 | 2013 | 254 | 0.100 |
Why?
|
| Interneurons | 1 | 2013 | 144 | 0.100 |
Why?
|
| Aspartic Acid Endopeptidases | 4 | 2005 | 44 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2012 | 106 | 0.100 |
Why?
|
| Motor Activity | 2 | 2013 | 693 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2013 | 298 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2016 | 554 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 927 | 0.090 |
Why?
|
| Humans | 25 | 2021 | 261506 | 0.080 |
Why?
|
| Rats | 5 | 2013 | 6086 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2007 | 164 | 0.080 |
Why?
|
| Motor Skills Disorders | 1 | 2006 | 20 | 0.070 |
Why?
|
| Urease | 1 | 2006 | 60 | 0.070 |
Why?
|
| Fabaceae | 1 | 2006 | 26 | 0.070 |
Why?
|
| Encephalitis | 1 | 2007 | 143 | 0.070 |
Why?
|
| Carbazoles | 1 | 2006 | 87 | 0.070 |
Why?
|
| Mutation | 5 | 2009 | 15179 | 0.070 |
Why?
|
| Pia Mater | 1 | 2005 | 14 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2006 | 187 | 0.070 |
Why?
|
| Cysteine | 1 | 2006 | 214 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 240 | 0.060 |
Why?
|
| Vimentin | 2 | 2022 | 253 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2006 | 192 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 871 | 0.060 |
Why?
|
| CHO Cells | 4 | 2008 | 311 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2005 | 217 | 0.060 |
Why?
|
| Lewy Bodies | 1 | 2003 | 10 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 7702 | 0.060 |
Why?
|
| Meclofenamic Acid | 1 | 2003 | 1 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 931 | 0.060 |
Why?
|
| Cell Line | 3 | 2013 | 5114 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 196 | 0.060 |
Why?
|
| Cricetinae | 4 | 2008 | 706 | 0.060 |
Why?
|
| Sulindac | 1 | 2003 | 51 | 0.060 |
Why?
|
| Solubility | 2 | 2018 | 242 | 0.060 |
Why?
|
| Central Nervous System Depressants | 1 | 2003 | 26 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 1304 | 0.060 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 2002 | 8 | 0.060 |
Why?
|
| Buspirone | 1 | 2002 | 7 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 641 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 503 | 0.060 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2002 | 13 | 0.060 |
Why?
|
| Mesencephalon | 1 | 2003 | 58 | 0.060 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 46 | 0.060 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 591 | 0.060 |
Why?
|
| Benzothiazoles | 2 | 2018 | 94 | 0.060 |
Why?
|
| Calcineurin | 2 | 2013 | 128 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2003 | 331 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2002 | 109 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 621 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2013 | 184 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2013 | 562 | 0.050 |
Why?
|
| Point Mutation | 1 | 2005 | 769 | 0.050 |
Why?
|
| Bacteria | 1 | 2006 | 611 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2021 | 27 | 0.050 |
Why?
|
| Peptides | 1 | 2008 | 1479 | 0.050 |
Why?
|
| Transgenes | 2 | 2018 | 557 | 0.050 |
Why?
|
| Neuroglia | 1 | 2003 | 223 | 0.050 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2021 | 16 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 57 | 0.050 |
Why?
|
| Materials Testing | 1 | 2021 | 116 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 4053 | 0.050 |
Why?
|
| Particle Size | 1 | 2021 | 182 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2006 | 786 | 0.050 |
Why?
|
| Protein Folding | 1 | 2021 | 281 | 0.050 |
Why?
|
| Posterior Cerebral Artery | 1 | 2020 | 8 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1582 | 0.050 |
Why?
|
| Microscopy, Ultraviolet | 1 | 2019 | 2 | 0.050 |
Why?
|
| Microtomy | 1 | 2019 | 17 | 0.050 |
Why?
|
| Mutagens | 1 | 2021 | 187 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2008 | 2086 | 0.050 |
Why?
|
| Female | 14 | 2018 | 141928 | 0.040 |
Why?
|
| Proteome | 1 | 2003 | 561 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 862 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 156 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 265 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 252 | 0.040 |
Why?
|
| Fetus | 1 | 2002 | 601 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 125 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2003 | 5270 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 995 | 0.040 |
Why?
|
| Microcirculation | 1 | 2019 | 200 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 591 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 1879 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 5710 | 0.040 |
Why?
|
| Clusterin | 1 | 2018 | 28 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2018 | 82 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 4938 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 1643 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 663 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2006 | 6150 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 671 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2003 | 1549 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 2063 | 0.030 |
Why?
|
| Genotype | 2 | 2018 | 4109 | 0.030 |
Why?
|
| Stem Cells | 1 | 2002 | 1213 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 891 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2007 | 177 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 4821 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 1020 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 573 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2008 | 2947 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 15193 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2003 | 2295 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 32848 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2002 | 5637 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 875 | 0.030 |
Why?
|
| Binding Sites | 2 | 2008 | 2171 | 0.030 |
Why?
|
| Cell Survival | 2 | 2013 | 3045 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 3536 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2005 | 151 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 11965 | 0.030 |
Why?
|
| Protein Binding | 2 | 2012 | 3438 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2013 | 8 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 6089 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 169 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 1487 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2012 | 41 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 600 | 0.030 |
Why?
|
| Pregnancy | 2 | 2003 | 7573 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 63 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2013 | 154 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2005 | 702 | 0.030 |
Why?
|
| Formoterol Fumarate | 1 | 2012 | 51 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 2054 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1648 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 4233 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 264 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 7548 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2016 | 403 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2013 | 190 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 388 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 176 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 703 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2013 | 426 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 254 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 160 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 1489 | 0.030 |
Why?
|
| Exercise Test | 1 | 2013 | 312 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2002 | 4078 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2013 | 176 | 0.030 |
Why?
|
| Epinephrine | 1 | 2012 | 255 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 249 | 0.030 |
Why?
|
| Mucins | 1 | 2012 | 285 | 0.030 |
Why?
|
| Male | 7 | 2013 | 123000 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 548 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 238 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Bronchi | 1 | 2012 | 326 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 5047 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 443 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2003 | 3518 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 671 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 5377 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 2961 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 615 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 669 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 3151 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 205 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 2927 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 549 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 694 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 2450 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 28 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 2146 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2006 | 42 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2006 | 73 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2007 | 229 | 0.020 |
Why?
|
| RNA Stability | 1 | 2006 | 125 | 0.020 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2005 | 15 | 0.020 |
Why?
|
| Fenofibrate | 1 | 2005 | 57 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2008 | 383 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2005 | 79 | 0.020 |
Why?
|
| Celecoxib | 1 | 2005 | 200 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2006 | 512 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 682 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2005 | 85 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 889 | 0.020 |
Why?
|
| Receptor, ErbB-4 | 1 | 2003 | 23 | 0.010 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2003 | 6 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 190 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1037 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 227 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2992 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 208 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.010 |
Why?
|
| Aged | 3 | 2013 | 70117 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2003 | 218 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 4917 | 0.010 |
Why?
|
| Serotonin | 1 | 2003 | 264 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 1764 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 14551 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 3472 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 6295 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 726 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1618 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 1029 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 2944 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 1328 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 1265 | 0.010 |
Why?
|
| DNA Damage | 1 | 2006 | 1954 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 4804 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2005 | 1471 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 1823 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 3154 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 2819 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 86204 | 0.000 |
Why?
|